Organon Canada Expands Nduvra Use to Atopic Dermatitis
Organon Canada expands the use of Nduvra to moderate to severe atopic dermatitis, marking the second approved indication for tapinarof cream in the country.
Organon Canada Expansion | 29/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy